Elsevier

Thrombosis Research

Volume 195, November 2020, Pages 74-76
Thrombosis Research

Letter to the Editors-in-Chief
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

https://doi.org/10.1016/j.thromres.2020.07.016Get rights and content

Highlights

  • The prevalence of aPL antibodies is poorly documented in ICU COVID-19 patients.

  • LA based on dRVVT system was positive in 85% of critically ill COVID-19 patients.

  • LA was not associated with thrombotic complications.

  • The prevalence of elevated anticardiolipin IgG/M/anti-beta2-GPI IgG was of 12%.

Keywords

COVID-19
Anticardiolipin
Anti-β2-glycoprotein-I
Lupus anticoagulant
Thrombosis

Cited by (0)

View Abstract